US-based vaccine management company VaxAtlas has developed a digital platform to aid the Covid-19 vaccination process.
Leveraging a range of on-demand tools, this platform will enable individuals to schedule and manage their vaccinations by providing them with access to a nationally certified pharmacy network.
These include community pharmacies in areas hardest hit by the pandemic, the company said.
The platform will also offer local appointments, location-based scheduling, recall alerts, second dose reminders, as well as second dose scheduling reminders.
In addition, it will offer credible vaccination validation with QR codes.
VaxAtlas CEO and founder Judi Korzec said: “With no structured approach to reopening, the vaccine management process will be confusing and hard to navigate.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“We want to alleviate the chaos and confusion of waiting in lines, scheduling or being turned away because of supply issues while providing tools to make lives easier for families, employers, travellers, and physicians.”
VaxAtlas platform, which leverages current payment and eligibility standards, is claimed to be HIPAA compliant.
The company was previously involved in the vaccine management during the H1N1 pandemic as well as provided backend support for Medicare Part D transition.
Covid-19 vaccine efforts have begun in the US, with major pharmaceutical firm Pfizer shipping the first batch of the newly authorised coronavirus vaccine.
Last week, Tampa General Hospital opened the new Taneja Family Global Emerging Diseases Institute in Florida, that will offer treatment for patients suffering from Covid-19 and other infectious diseases.